Search for: "WYETH AYERST LABORATORIES INC." Results 21 - 40 of 47
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Sep 2009, 11:22 pm
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004), and Desiano v. [read post]
6 Jul 2007, 4:29 am
Wyeth Laboratories, Inc., 533 N.E.2d 748, 755 (Ohio 1988). [read post]
11 Sep 2012, 11:36 am by Bexis
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004), that the fraud exception to Michigan’s bar on products liability suits against drug manufacturers is preempted, even where Plaintiffs haven’t alleged fraud-on-the-FDA in the classical sense.Plaintiffs brought consolidated products-liability actions against drug manufacturers Genentech, Inc. and Xoma (U.S.) [read post]
27 May 2010, 3:40 pm by Bexis
Wyeth-Ayerst Laboratories, 1996 WL 784566 (N.D. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Wyeth-Ayerst Laboratories Co., appears to recognize that risk and cause are distinct concepts. 278 F. [read post]
12 Mar 2024, 12:46 pm by admin
Wyeth-Ayerst Laboratories Co., 278 F.Supp.2d 684, 700 (W.D.N.C. 2003) (expert witnesses may not opine about corporate intent and motive) (barring Dr. [read post]
5 Jun 2013, 5:29 am by Schachtman
Merrill-National Laboratories, 646 F.Supp. 856 (D. [read post]
14 Mar 2008, 6:07 am
Wyeth-Ayerst Laboratories Co., the court encountered the redoubtable (we would say, very doubtable) Dr. [read post]
23 Sep 2010, 11:56 am by Bexis
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004)]. . . . [read post]
18 Mar 2011, 10:04 am by Schachtman
Wyeth-Ayerst Laboratories Co., appears to recognize that risk and cause are distinct concepts. 278 F. [read post]
28 Jun 2007, 10:16 am
Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), and Williams v. [read post]
3 Jun 2010, 1:37 pm by Bexis
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004); White v. [read post]